Resources from the same session
3336 - CD13 and CD33 CAR-T cells for the treatment of myeloid malignancies.
Presenter: Koon Lee
Session: Poster Discussion session - Haematological malignancies
Resources:
Abstract
5735 - The identification of the AXL/Gas6 signalling axis as a key player of myelodysplastic syndrome (MDS) and the potential of the oral selective AXL inhibitor bemcentinib in the treatment of MDS
Presenter: Hind Medyouf
Session: Poster Discussion session - Haematological malignancies
Resources:
Abstract
2782 - ALK positive Anaplastic large cell lymphoma: molecular diagnosis and minimal residual disease monitoring
Presenter: Marketa Kalinova
Session: Poster Discussion session - Haematological malignancies
Resources:
Abstract
3796 - Intensified 14 day rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (RCHOP14) compared to RCHOP21 in patients with newly diagnosed diffuse large B cell lymphoma (DLBCL): A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Presenter: Jose Sandoval-Sus
Session: Poster Discussion session - Haematological malignancies
Resources:
Abstract
2417 - Evaluation of safety, tolerability and efficacy of Temsirolimus in patients (pts) with relapsed or refractory mantle cell lymphoma (rel/refr MCL) in routine clinical practice
Presenter: Martin Dreyling
Session: Poster Discussion session - Haematological malignancies
Resources:
Abstract
5119 - A comparative study of 18F-FDG PET/CT with bilateral bone marrow trephine biopsy for assessment of bone marrow infiltration by lymphoma
Presenter: Durairaj Arjunan
Session: Poster Discussion session - Haematological malignancies
Resources:
Abstract
2586 - Phase I/II, first in human trial with M7583, a Bruton’s tyrosine kinase inhibitor (BTKi), in patients with B cell malignancies
Presenter: Wojceich Jurczak
Session: Poster Discussion session - Haematological malignancies
Resources:
Abstract
4219 - A prospective study of first-line Helicobacter pylori eradication therapy in treating localized extragastric mucosa-associated lymphoid tissue lymphoma
Presenter: Sung-Hsin Kuo
Session: Poster Discussion session - Haematological malignancies
Resources:
Abstract
2563 - Bendamustine and rituximab followed by 90Y-ibritumomab tiuxetan for relapsed follicular lymphoma; a preliminary analysis of a multicenter, prospective phase II study (BRiZ2012).
Presenter: Masatoshi Kanno
Session: Poster Discussion session - Haematological malignancies
Resources:
Abstract
Poster Discussion session - Haematological malignancies - Invited Discussant 1014PD, 1015PD and 1016PD
Presenter: Michele Ghielmini
Session: Poster Discussion session - Haematological malignancies
Resources:
Slides
Webcast